Cost-effectiveness of revised US pneumococcal vaccination recommendations in underserved minority adults < 65-years-old
Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman, Kenneth J. Smith
Topics & Concepts
MedicinePneumococcal conjugate vaccinePneumococcal polysaccharide vaccineVaccinationPopulationCost effectivenessDemographyPneumococcal vaccinePediatricsEnvironmental healthImmunologyPneumococcal diseaseStreptococcus pneumoniaeGeneticsBacteriaSociologyRisk analysis (engineering)BiologyPneumonia and Respiratory InfectionsInfluenza Virus Research StudiesRespiratory viral infections research